FDA expands COVID-19 testing options via spun synthetic swabs
The Food and Drug Administration yesterday announced that spun synthetic swabs made from materials like polyester can be used for test patients for COVID-19.
FDA based its decision on a clinical investigation that revealed that synthetic swabs can be used for front-of-the-nose testing, which is considered more comfortable for patients, allows for self-testing and limits health care providers’ exposure. To support this declaration, U.S. Cotton says it will produce these new polyester swabs in large quantities to help meet coronavirus diagnostic testing needs.
Related News Articles
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…